Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Epithelial Cancer Recurrent × Trabectedin × Gynecologic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 15 Neoplasms 3 Sarcoma 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Uterine Neoplasms 1 Sarcoma, Synovial 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Recurrence 1 Peritoneal Neoplasms 1 Ovarian Epithelial Cancer Recurrent 1 Ovarian Diseases 1 Neurofibrosarcoma 1 Neoplasms by Site 1 Malignant mesenchymal tumor 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Hemangiopericytoma, Malignant 1 Genital Diseases, Female 1 Gastrointestinal Stromal Tumors 1 Fibrosarcoma 1 Fanconi Anemia, Complementation Group D1 1 Endocrine Gland Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma 1

Interventions

liposomal doxorubicin 1 Trabectedin 1 Hyperthermic Intraperitoneal Chemotherapy 1 Docetaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02394015 2020-03-27

RETRO-ROC

Grupo Español de Investigación en Cáncer de Ovario

Ovarian Epithelial Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡